News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Jame Abraham: Looking Forward to Seeing You at ASCO 2025 in Chicago
Jame Abraham/my.clevelandclinic.org
May 31, 2025, 11:32

Jame Abraham: Looking Forward to Seeing You at ASCO 2025 in Chicago

Jame Abraham, Chairman and Professor of the Department of Hematology and Medical Oncology at Cleveland Clinic, shared a post on LinkedIn:

“Looking forward to seeing you at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago! Please visit the Cleveland Clinic Cancer Center booth in the exhibit area!”

Jame Abraham: Looking Forward to Seeing You at ASCO 2025 in Chicago

More posts featuring Jame Abraham.

ASCO 2025 ASCO25 cancer Cleveland Clinic Jame Abraham OncoDaily Oncology
Special Coverage
Blog
Jun 3, 2025, 10:50
Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd
Opinion
Jun 3, 2025, 10:41
TRIgnite-1 study at ASCO 2025 showed High Response Rates and Favorable Safety Profile for the Treatment of Relapsed/Refractory Multiple Myeloma with First-in-Class BCMA × CD38 × CD3 Trispecific Antibody 
Blog
Jun 3, 2025, 10:35
Mario Balsa Shares ASCENT-04 Trial Results in First-Line mTNBC at ASCO25
Blog
Jun 3, 2025, 10:33
Vivek Subbiah: Waiting for ASCO 2025 Hematology Discussions with Naveen Pemmaraju
Blog
Jun 3, 2025, 10:27
Supriya Peshin Reflects on a Memorable Moment with Oncology Colleagues
Blog
Jun 3, 2025, 09:54
Robin Zon: ASCO 2025 President’s Address - “Driving Knowledge to Action: Building a Better Future”
Science
Jun 3, 2025, 09:52
Breaking research on GLP-1s and cancer from ASCO 2025
Blog
Jun 3, 2025, 09:48
Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25
Blog
Jun 3, 2025, 09:33
Sagal Pannu: Tarlatamab and Emerging Bispecific T-cell Engagers Changing the Treatment Landscape of SCLC
Blog
Jun 3, 2025, 09:25
Nehemias Guevara-Rodriguez: Honored to Meet Saad Z. Usmani a Giant in Cancer Care
Blog
Jun 3, 2025, 09:15
Harold J. Burstein: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
Blog
Jun 3, 2025, 09:06
Bishal Gyawali: Why Surrogate Endpoints Shouldn’t Justify Full Cancer Drug Approvals